Page last updated: 2024-11-05

ici 204,219 and Cough

ici 204,219 has been researched along with Cough in 2 studies

zafirlukast: a leukotriene D4 receptor antagonist

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dicpinigaitis, PV2
Dobkin, JB2
Reichel, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Utility of feNO in the Differential Diagnosis of Chronic Cough: The Response to Anti-inflammatory Therapy With Prednisolone and Montelukast[NCT02479074]Phase 449 participants (Actual)Interventional2016-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for ici 204,219 and Cough

ArticleYear
Effect of zafirlukast on cough reflex sensitivity in asthmatics.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1999, Volume: 36, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Asthmatic Agents; Asthma; Capsaicin; Cough; Cross-Over Studi

1999
Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2002, Volume: 39, Issue:4

    Topics: Adult; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Capsaicin; Cough; Cross-Over Stud

2002